The Question Is Whether To Buy Or Not To Buy Catalyst Pharmaceuticals Inc (NASDAQ: CPRX)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Catalyst Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $14.43 and fluctuated between $14.60 as its day high and $14.34 as its day low. The current market capitalization of Catalyst Pharmaceuticals Inc is $1.55B. A total of 0.66 million shares were traded on the day, compared to an average of 1.44M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CPRX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 29 BUYs and 21 SELLs from insiders. Insiders purchased 914,163 shares during that period but sold 330,952.

In the most recent transaction, Harper Molly sold 14,000 shares of CPRX for 14.39 per share on Dec 15. After the transaction, the Director now owns 0 company shares. In a previous transaction on Dec 12, Tierney David S sold 50,000 shares at 13.32 per share. CPRX shares that Director owns now total 333,541.

Among the insiders who sold shares, GRANDE ALICIA disposed of 60,000 shares on Dec 11 at a per-share price of $13.76. This resulted in the VP, Treasurer and CFO holding 50,557 shares of CPRX after the transaction. In another insider transaction, GRANDE ALICIA sold 40,000 shares at $14.28 per share on Dec 08. Company shares held by the VP, Treasurer and CFO now total 50,557.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CPRX in the last 3 months, the mean price target is $26.20 with high estimates of $30.00 and low estimates of $24.00. In terms of 52-week highs and lows, CPRX has a high of $18.22 and a low of $11.09.

As of this writing, CPRX has an earnings estimate of $0.26 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.32 per share and a lower estimate of $0.23. The company reported an EPS of $0.33 in the last quarter, which was -8.30% lower than expectations of $0.36.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CPRX’s latest balance sheet shows that the firm has $191.27M in Cash & Short Term Investments as of fiscal 2021. There were $4.20M in debt and $27.06M in liabilities at the time. Its Book Value Per Share was $3.27, while its Total Shareholder’s Equity was $206.83M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CPRX is Buy with a score of 5.00.

Most Popular

Related Posts